Showing results (131-140 of 190) with videos related to
Sort By:
Pageof 19
Oncotarget|September 15, 2017
Toxicology and efficacy of tumor-targeting Salmonella typhimurium A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent miceYong Zhang, Wenluo Cao, Makoto Toneri, et al.Journal of the American Medical Informatics Association : JAMIA|March 13, 2021
DDIWAS: High-throughput electronic health record-based screening of drug-drug interactionsPatrick Wu, Scott D Nelson, Juan Zhao, et al.Journal of Drug Targeting|July 20, 2018
Patterns of sensitivity to a panel of drugs are highly individualised for undifferentiated/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse modelsKei Kawaguchi, Kentaro Igarashi, Kentaro Miyake, et al.Oncotarget|November 22, 2017
Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse modelKei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.Tissue & Cell|May 29, 2019
Temozolomide targets and arrests a doxorubicin-resistant follicular dendritic-cell sarcoma patient-derived orthotopic xenograft mouse modelHiromichi Oshiro, Yasunori Tome, Tasuku Kiyuna, et al.The Journal of Trauma and Acute Care Surgery|September 13, 2024
Comparison of thoracic epidural catheter and continuous peripheral infusion for management of traumatic rib fracture painRobel T Beyene, Marshall W Wallace, Nicholas Statzer, et al.Translational Oncology|January 4, 2020
Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse ModelKentaro Igarashi, Kei Kawaguchi, Ming Zhao, et al.Oncotarget|October 6, 2017
A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncologyKentaro Igarashi, Takashi Murakami, Kei Kawaguchi, et al.Oncotarget|October 4, 2017
A novel anionic-phosphate-platinum complex effectively targets an undifferentiated pleomorphic sarcoma better than cisplatinum and doxorubicin in a patient-derived orthotopic xenograft (PDOX)Kentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.Tissue & Cell|May 29, 2019
Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.Pageof 19